Emilio J. Laserna‐Mendieta

Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease

Feargal J. Ryan, Anna M. Ahern, Rachel S. Fitzgerald et al. · Nature Communications · 2020 · 283 citations · Full text

Life Sciences, Immunology, Microbiology +17

Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study

Adam G. Clooney, Julia Eckenberger, Emilio J. Laserna‐Mendieta et al. · Gut · 2020 · 250 citations · Full text

Life Sciences, Microbiology, Metagenomics +16

A comparison of the gut microbiome between long‐term users and non‐users of proton pump inhibitors

Adam G. Clooney, Çharles N. Bernstein, William D. Leslie et al. · Alimentary Pharmacology & Therapeutics · 2016 · 164 citations

Life Sciences, Microbiology, Epidemiology +16

Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry

Emilio J. Laserna‐Mendieta, Sergio Casabona, Danila Guagnozzi et al. · Alimentary Pharmacology & Therapeutics · 2020 · 130 citations

Medicine, Internal Medicine, Pharmacotherapy +14

Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn’s Disease and Ulcerative Colitis

Emilio J. Laserna‐Mendieta, Adam G. Clooney, Juana Carretero‐Gómez et al. · Journal of Crohn s and Colitis · 2017 · 122 citations

Life Sciences, Microbiology, Nutritional Sciences +17